Strata Critical Medical Inc Warrants
SRTAW
SRTAW was delisted on the 6th of May, 2026.
11 hedge funds and large institutions have $661K invested in Strata Critical Medical Inc Warrants in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
1.63% less ownership
Funds ownership: 10.15% → 8.53% (-1.6%)
75% less capital invested
Capital invested by funds: $2.64M → $661K (-$1.98M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$3.98K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$130K |
| 2 |
Morgan Stanley
New York
|
-$119K |
| 3 |
Walleye Capital
New York
|
-$25K |
| 4 |
HF
HRT Financial
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $240K | – | – | – |
|
|
2
Walleye Capital
New York
| $225K | -$25K | -147,273 | -6% |
|
|
LP
3
LMR Partners
London,
United Kingdom
| $108K | – | – | – |
|
|
4
Morgan Stanley
New York
| $73.2K | -$119K | -700,000 | -50% |
|
|
CAC
5
Cowen and Company
New York
| $4.96K | – | – | – |
|
6
Two Sigma Investments
New York
| $3.9K | – | – | – |
|
|
SCM
7
Saba Capital Management
New York
| $3.13K | – | – | – |
|
|
WAM
8
Wolverine Asset Management
Chicago,
Illinois
| $2.45K | +$3.98K | +23,420 | New |
|
|
TPCW
9
TD Private Client Wealth
New York
| $63 | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $6 | +$9 | +54 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $2 | – | – | – |
|
|
ICM
12
Ionic Capital Management
New York
| – | -$130K | -371,749 | Closed |
|
|
HF
13
HRT Financial
New York
| – | -$3K | -10,569 | Closed |
|
SRTAW Hedge Fund Activity: Q1 2024 in Review
11 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q1 2024, worth a combined $661K — down 75% from $2.64M a quarter earlier.
Fund positioning in SRTAW was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $3.98K. The largest seller was Ionic Capital Management, exiting entirely with an estimated $130K sold.
- 11 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $661K of Strata Critical Medical Inc Warrants stock for Q1 2024, down 75% quarter-over-quarter.
- 2 funds opened new Strata Critical Medical Inc Warrants positions in Q1 2024 and 2 closed out, a net change of 0 holders.
- The largest Strata Critical Medical Inc Warrants buyer in Q1 2024 was Wolverine Asset Management, an estimated $3.98K added.
- The largest Strata Critical Medical Inc Warrants seller in Q1 2024 was Ionic Capital Management, an estimated $130K sold.
Based on aggregated 13F filings for Q1 2024.